Endothelial cell injury and dysfunction induced by silver nanoparticles through oxidative stress via IKK/NF-κB pathways

Biomaterials

Volumn 35, Issue 24, 2014, Pages 6657-6666

  Shi, Junpeng ^a   Sun, Xia ^a   Lin, Yi ^a   Zou, Xiaoyan ^a   Li, Zhanjun ^a   Liao, Yanyan ^a   Du, Miaomiao ^a   Zhang, Hongwu ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Atherosclerosis; Endothelium; NF B; Reactive oxygen species; Silver nanoparticles

Indexed keywords

ACETYLCYSTEINE; ADHESION; AMINO ACIDS; CELL DEATH; CELL MEMBRANES; CHEMICAL ACTIVATION; DISEASES; NANOPARTICLES; SILVER; TOXICITY;

ATHEROSCLEROSIS; ENDOTHELIUM; EPIDEMIOLOGICAL STUDIES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; INFLAMMATORY CYTOKINES; REACTIVE OXYGEN SPECIES; SILVER NANOPARTICLES; SILVER NANOPARTICLES (AGNPS);

ENDOTHELIAL CELLS;

AUTACOID; CCL2 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CYTOKINE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METAL NANOPARTICLE; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; SILVER;

APOPTOSIS; CELL ADHESION; CELL DEATH; CYTOLOGY; DRUG EFFECTS; ENDOCYTOSIS; HUMAN; METABOLISM; MONOCYTE; OXIDATIVE STRESS; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOXICITY; TUMOR CELL LINE; ULTRASTRUCTURE; UMBILICAL VEIN ENDOTHELIAL CELL;

APOPTOSIS; CELL ADHESION; CELL ADHESION MOLECULES; CELL DEATH; CELL LINE, TUMOR; CHEMOKINE CCL2; CYTOKINES; ENDOCYTOSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; I-KAPPA B KINASE; INFLAMMATION MEDIATORS; METAL NANOPARTICLES; MONOCYTES; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SILVER;

EID: 84901394106     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.093     Document Type: Article

References (34)

1. Weber C., Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011, 17:1410-1422.
2. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009, 27:165.
3. Adar S.D., Sheppard L., Vedal S., Polak J.F., Sampson P.D., Roux A.V.D., et al. Fine particulate air pollution and the progression of carotid intima-medial thickness: a prospective cohort study from the multi-ethnic study of atherosclerosis and air pollution. PloS Med 2013, 10:e1001430.
4. Barreto J.A., O'Malley W., Kubeil M., Graham B., Stephan H., Spiccia L. Nanomaterials: applications in cancer imaging and therapy. Adv Mater 2011, 23:H18-H40.
5. Yong K.-T., Law W.-C., Hu R., Ye L., Liu L., Swihart M.T., et al. Nanotoxicity assessment of quantum dots: from cellular to primate studies. Chem Soc Rev 2013, 42:1236-1250.
6. Pacurari M., Yin X.J., Zhao J., Ding M., Leonard S.S., Schwegler-Berry D., et al. Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-κB, and Akt in normal and malignant human mesothelial cells. Environ Health Perspect 2008, 116:1211.
7. Rahman M., Wang J., Patterson T., Saini U., Robinson B., Newport G., et al. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 2009, 187:15-21.
8. Zhu M.-T., Wang B., Wang Y., Yuan L., Wang H.-J., Wang M., et al. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol Lett 2011, 203:162-171.
9. Kang G.S., Gillespie P.A., Gunnison A., Luis Moreira A., Tchou-Wong K.-M., Chen L.-C. Long-term inhalation exposure to nickel nanoparticles exacerbated atherosclerosis in a susceptible mouse model. Environ Health Perspect 2011, 119:176.
10. Mikkelsen L., Sheykhzade M., Jensen K.A., Saber A.T., Jacobsen N.R., Vogel U., et al. Modest effect on plaque progression and vasodilatory function in atherosclerosis-prone mice exposed to nanosized TiO(2). Part Fibre Toxicol 2011, 8:32.
11. Choi S., Dickson R.M., Yu J. Developing luminescent silver nanodots for biological applications. Chem Soc Rev 2012, 41:1867-1891.
12. Marambio-Jones C., Hoek E.M. Areview of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. JNanopart Res 2010, 12:1531-1551.
13. Radetić M. Functionalization of textile materials with silver nanoparticles. JMater Sci 2013, 48:95-107.
14. Wijnhoven S.W., Peijnenburg W.J., Herberts C.A., Hagens W.I., Oomen A.G., Heugens E.H., et al. Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3:109-138.
15. Wang Z., Liu S., Ma J., Qu G., Wang X., Yu S., et al. Silver nanoparticles induced RNA polymerase-silver binding and RNA transcription inhibition in erythroid progenitor cells. ACS Nano 2013, 7:4171-4186.
16. Kalishwaralal K., Banumathi E., Pandian S.R.K., Deepak V., Muniyandi J., Eom S.H., et al. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf B Biointerfaces 2009, 73:51-57.
17. AshaRani P., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS nano 2008, 3:279-290.
18. Guo D., Zhu L., Huang Z., Zhou H., Ge Y., Ma W., et al. Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. Biomaterials 2013, 34:7884-7894.
19. Gurunathan S., Lee K.-J., Kalishwaralal K., Sheikpranbabu S., Vaidyanathan R., Eom S.H. Antiangiogenic properties of silver nanoparticles. Biomaterials 2009, 30:6341-6350.
20. Albini A., Mussi V., Parodi A., Ventura A., Principi E., Tegami S., et al. Interactions of single-wall carbon nanotubes with endothelial cells. Nanomed Nanotechnol Biol Med 2010, 6:277-288.
21. Alom-Ruiz S.P., Anilkumar N., Shah A.M. Reactive oxygen species and endothelial activation. Antioxid Redox Signal 2008, 10:1089-1100.
22. Davda J., Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002, 233:51-59.
23. Ishikado A., Nishio Y., Yamane K., Mukose A., Morino K., Murakami Y., et al. Soy phosphatidylcholine inhibited TLR4-mediated MCP-1 expression in vascular cells. Atherosclerosis 2009, 205:404-412.
24. Jiang B., Liang P., Zhang B., Song J., Huang X., Xiao X. Role of PPAR-beta in hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells. Atherosclerosis 2009, 204:353-358.
25. Turkevich J., Stevenson P.C., Hillier J. Astudy of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 1951, 11:55-75.
26. Choy J.C., Granville D.J., Hunt D.W., McManus B.M. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. JMol Cell Cardiol 2001, 33:1673-1690.
27. Kampoli A.-M., Tousoulis D., Antoniades C., Siasos G., Stefanadis C. Biomarkers of premature atherosclerosis. Trends Mol Med 2009, 15:323-332.
28. Niu J., Kolattukudy P. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin Sci 2009, 117:95-109.
29. Yadav A., Saini V., Arora S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010, 411:1570-1579.
30. Galkina E., Ley K. Vascular adhesion molecules in atherosclerosis. Artertioscler Thromb Vasc Biol 2007, 27:2292-2301.
31. Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170:191-203.
32. Kumar A., Takada Y., Boriek A.M., Aggarwal B.B. Nuclear factor-κB: its role in health and disease. JMol Med 2004, 82:434-448.
33. Hayden M.S., Ghosh S. Signaling to NF-κB. Genes Dev 2004, 18:2195-2224.
34. Baeuerle P.A., Henkel T. Function and activation of NF-kappaB in the immune system. Annu Rev Immunol 1994, 12:141-179.